Related references
Note: Only part of the references are listed.The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging
Adriana T. Perles-Barbacaru et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Tumor delivery of macromolecular drugs based on the EPR effect
Vladimir Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2011)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype
Mohamed Abdelkarim et al.
PLOS ONE (2011)
Mouse models of advanced spontaneous metastasis for experimental therapeutics
Giulio Francia et al.
NATURE REVIEWS CANCER (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations
Victoria C. Cogger et al.
JOURNAL OF STRUCTURAL BIOLOGY (2010)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Human tumor xenografts and mouse models of human tumors: re-discovering the models
Beverly A. Teicher
EXPERT OPINION ON DRUG DISCOVERY (2009)
Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours
Sarah Jane Lunt et al.
BMC CANCER (2008)
Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies
Kyoko Hida et al.
CANCER SCIENCE (2008)
Diagnosis and management of lymphatic vascular disease
Stanley G. Rockson
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers
MR Dreher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice
RM Schiffelers et al.
NEOPLASIA (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors
P Baluk et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride
K Hori et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Tumor angiogenesis: past, present and the near future
RS Kerbel
CARCINOGENESIS (2000)
Share Paper
